Earnings History Data for Carisma Therapeutics, Inc. (CARM) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Carisma Therapeutics, Inc.
Carisma Therapeutics Inc. is a late-stage clinical company which focused on advancing targeted fusion protein therapeutics for the treatment of patients with cancer. The company's advanced product candidate includes Vicineum(TM). Carisma Therapeutics Inc., formerly known as Sesen Bio Inc., is based in CAMBRIDGE, Mass.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 07-11-2024 | PM | CARM | CARISMA THERAP | 46.00 | -0.31 | -0.31 | 0.00 | Carisma Therapeutics reports Q3 results [11/7/2024 9:05 AM] |
1.04 | -0.07 (-6.49%) |
1.08 | -0.03 (-2.70%) |
0.80 - 3.38 | 194,500 | 150,000 | 9,668 | ||
| 01-04-2024 | PM | CARM | CARISMA THERAP | 92.00 | -0.52 | -0.56 | 0.00 | Carisma Therapeutics GAAP EPS of -$0.52, revenue of $4.29M [4/1/2024 9:09 AM] |
2.09 | -0.18 (-7.93%) |
2.34 | 0.07 (3.08%) |
1.96 - 9.77 | 298,623 | 170,000 | 1,922 | ||
| 09-11-2023 | PM | CARM | CARISMA THERAP | 132.00 | -0.53 | -0.60 | 0.00 | Sesen Bio GAAP EPS of -$0.53 beats by $0.04, revenue of $3.83M beats by $2.94M [11/9/2023 7:47 AM] |
2.65 | -0.33 (-11.07%) |
0.0 | 0.0 (0.00%) |
2.62 - 9.77 | 77,602 | 150,000 | 0 | ||
| 10-08-2023 | PM | CARM | CARISMA THERAP | 225.00 | -0.49 | -0.66 | 0.00 | Sesen Bio GAAP EPS of -$0.49 beats by $0.11, revenue of $3.56M beats by $2.75M [8/10/2023 11:08 AM] |
5.93 | 0.34 (6.17%) |
0.0 | 0.0 (0.00%) |
2.75 - 9.77 | 138,955 | 270,000 | 0 | ||